Question 1

How many shares of PTGX does Ensign Peak Advisors, Inc own?

Accepted Answer

As of 2026-Q2, Ensign Peak Advisors, Inc holds 3,786 shares of PTGX (PROTAGONIST THERAPEUTICS INC).

Question 2

What is Ensign Peak Advisors, Inc's PTGX position worth?

Accepted Answer

As of 2026-Q2, Ensign Peak Advisors, Inc's PTGX position is worth $464,088.

Question 3

Is Ensign Peak Advisors, Inc buying or selling PTGX?

Accepted Answer

In 2026-Q2, Ensign Peak Advisors, Inc decreased their PTGX position (-15.6% change in shares).

Question 4

When did Ensign Peak Advisors, Inc first buy PTGX?

Accepted Answer

Based on available 13F filings, Ensign Peak Advisors, Inc first reported a position in PTGX in 2024-Q3. They have held the position across 23 quarters.

Quarter	Action	Shares	Change	Value	Weight	Price
2026-Q2 Latest	Decreased	3,786	-15.6%	$464,088	0.0%	$122.58
2026-Q1	Unchanged	4,486	0.0%	$472,824	0.0%	$91.30
2025-Q4	Decreased	4,486	-59.2%	$391,807	0.0%	$87.26
2025-Q3	Decreased	10,986	-52.5%	$729,800	0.0%	$65.14
2025-Q2	Decreased	23,136	-14.4%	$1.3M	0.0%	$55.69
2025-Q1	Unchanged	27,036	0.0%	$1.3M	0.0%	$48.88
2024-Q4	Unchanged	27,036	0.0%	$1M	0.0%	$38.51
2024-Q3	Unchanged	27,036	0.0%	$1.2M	0.0%	$44.56